Stock Under $10 with 50-100% upside potential - 14 Days FREE!

4 Biotech Stocks Under $10 Moving Higher

Stock quotes in this article: GALE, CYCC, NYMX, ACAD 

Galena Biopharma

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Galena Biopharma (GALE) is a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics. This stock is trading up 6.8% to $2.01 in recent trading.

Today's Range: $1.95-$2.07

52-Week Range: $0.36-$3.54

Volume: 1.7 million

Three-Month Average Volume: 1.3 million

>>3 Hot Stocks to Trade (or Not)

From a technical perspective, GALE is trending higher here with above-average volume. This move is quickly pushing GALE within range of triggering a major breakout trade. That trade will hit once GALE manages to clear some near-term overhead resistance levels at $2.19 to $2.30 with high volume.

Traders should now look for long-biased trades in GALE as long as it's trending above its 50-day at $1.83, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.3 million shares. If that breakout triggers soon, then look for GALE to re-test or possibly take out its next major overhead resistance levels at $2.50 to $2.75. Any high-volume move above $2.75 will put $3.54 into focus for GALE.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,408.00 72.72 0.47%
NASDAQ 3,508.24 11.81 0.34%
S&P 500 1,672.24 5.95 0.36%
US 10 Yr 1.930% -0.035

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs